K+S

K+S diversifies in salt

03/06/26 -"K+S announced the acquisition of the salts business from Qemetica for €350m, plus a potential €30m earn-out. While the deal values the assets at approximately 7.0x EV/EBITDA, expected synergies could ..."

PDF page sample
Pages
53
Language
English
Published on
03/06/26
Download
You may also be interested by these reports :
03/06/26
K+S announced the acquisition of the salts business from Qemetica for €350m, plus a potential €30m earn-out. While the deal values the assets at ...
28/05/26
H2 2025/26 remained a mixed bag for JMAT, with weak demand and metal losses weighing on Clean Air and PGM Services. EBIT remained dependent on cost ...
27/05/26
Akzo Nobel rejected a €13bn bid from Nippon Paint and Sherwin-Williams, despite the offer implying a 39% premium to its share price. Positive ...
20/05/26
2026/2027: EPS increase is driven by a strong Q1 2026 underpinning management expectations of €1.0bn in 2026 EBITDA. We remain optimistic on earnings ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO